MCQ Book Questions

Q55934. Low doses of heparin prolong

Q55935. Low molecular weight heparins differ from conventional heparin in that

Q55936. Initiation of unfractionated heparin therapy for the patient in question 1 would best be achieved with

Q55937. Which of the following can be used to antagonize the action of heparin in case of overdose ?

Q55938. Blood level of which clotting factor declines most rapidly after the initation of warfarin therapy

Q55939. The following drug reduces the effect of oral anticoagulants

Q55940. The most definite beneficial results are obtained in the use of anticoagulants for the following purpose

Q55941. Anticoagulants are indicated in

Q55942. Which of the following tests are used to monitor antithrombotic therapy? I. International normalized ratio (INR) II. Activated partial thromboplastin time (APTT) III. Heparin assay

Q55943. Which fibrioolytic drug(s) is/are antigenic

Q55944. The most important complication of streptokinase therapy is

Q55945. A patient to be commenced on oral anticoagulant therapy for DVT would be treated with: I. Oral anticoagulant therapy with warfarin for a goal international normalized ratio (INR) of 2–3 II. Oral anticoagulant therapy with warfarin for a goal INR of 2.5–3.5 III. Oral anticoagulant therapy with aspirin for a goal INR of 2–3

Q55946. Thrombolytic therapy instituted within 3- 6 hours of onset of acute myocardial infarction affords the following benefit(s)

Q55947. The preferred route of administration of streptokinase in acute myocardial infarction is

Q55948. A patient on oral anticoagulant therapy is commenced on sulfamethoxazole- trimethoprim, double-strength twice daily. One may expect to see the INR I. Increase II. Decrease III. Remain unchanged

Q55949. Aspirin prolongs bleeding time by inhibiting the synthesis of

Q55950. Route of heparin administration is

Q55951. The anticoagulant effects of heparin can be promptly arrested by administration of

Q55952. Severe cases of bleeding due to fibrinolytic agents are treated with

Q55953. If a patient has an INR greater than 20 and active bleeding that is clinically significant (i.e., hematuria), the pharmacist should I. Hold the drug therapy II. Administer vitamin K III. Administer fresh frozen plasma